These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9616523

  • 1. Implementing the British Thoracic Society's guidelines: the effect of a nurse-run asthma clinic on prescribed treatment in an English general practice.
    Dickinson J, Hutton S, Atkin A.
    Respir Med; 1998 Feb; 92(2):264-7. PubMed ID: 9616523
    [Abstract] [Full Text] [Related]

  • 2. Reducing asthma morbidity in the community: the effect of a targeted nurse-run asthma clinic in an English general practice.
    Dickinson J, Hutton S, Atkin A, Jones K.
    Respir Med; 1997 Nov; 91(10):634-40. PubMed ID: 9488898
    [Abstract] [Full Text] [Related]

  • 3. Morbidity from asthma in relation to regular treatment: a community based study.
    Walsh LJ, Wong CA, Cooper S, Guhan AR, Pringle M, Tattersfield AE.
    Thorax; 1999 Apr; 54(4):296-300. PubMed ID: 10092689
    [Abstract] [Full Text] [Related]

  • 4. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Paré P.
    CMAJ; 2001 Mar 06; 164(5):625-31. PubMed ID: 11258208
    [Abstract] [Full Text] [Related]

  • 5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 06; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 6. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G, Williams DA, Weller P, Price JF.
    Ann Allergy Asthma Immunol; 1995 Nov 06; 75(5):423-8. PubMed ID: 7583864
    [Abstract] [Full Text] [Related]

  • 7. Asthma-related prescribing patterns with four different corticosteroid inhaler devices.
    Frost GD, Penrose A, Hall J, MacKenzie DI.
    Respir Med; 1998 Dec 06; 92(12):1352-8. PubMed ID: 10197229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
    Murray JJ, Church NL, Anderson WH, Bernstein DI, Wenzel SE, Emmett A, Rickard KA.
    Allergy Asthma Proc; 1999 Dec 06; 20(3):173-80. PubMed ID: 10389550
    [Abstract] [Full Text] [Related]

  • 10. Adherence to asthma guidelines in general practices.
    Roghmann MC, Sexton M.
    J Asthma; 1999 Jun 06; 36(4):381-7. PubMed ID: 10386502
    [Abstract] [Full Text] [Related]

  • 11. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 12. Changes to inhaled corticosteroid dose when initiating combination inhaler therapy in long-acting β agonist-naïve patients with asthma: a retrospective database analysis.
    Covvey JR, Johnston BF, Wood F, Boyter AC.
    Thorax; 2014 Nov 11; 69(11):1056-8. PubMed ID: 24430175
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group.
    Jones KP.
    Thorax; 1994 Oct 11; 49(10):971-5. PubMed ID: 7974313
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology.
    Laumann JM, Bjornson DC.
    Ann Pharmacother; 1998 Dec 11; 32(12):1290-4. PubMed ID: 9876808
    [Abstract] [Full Text] [Related]

  • 17. [Control of asthma by treatment with inhaled corticosteroids and prolonged action beta 2-agonists in free or fixed combination. Results of the ALISE study].
    Serrier P, Roche N, Pello JY, Larguier JS, Mezzi K.
    Presse Med; 2003 Mar 22; 32(11):493-7. PubMed ID: 12733387
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population.
    Castellsague J, Garcia-Rodríguez LA, Pérez-Gutthann S, Agostinis L, Cattaruzi C, Troncon MG.
    Respir Med; 1999 Oct 22; 93(10):709-14. PubMed ID: 10581659
    [Abstract] [Full Text] [Related]

  • 19. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA, Seltzer JM, Kemp JP, Chervinsky P, Alexander WJ, Liddle R, Mills R.
    Ann Allergy Asthma Immunol; 1995 Sep 22; 75(3):243-8. PubMed ID: 7552926
    [Abstract] [Full Text] [Related]

  • 20. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA, Kemp JP, Orgel HA, Bierman CW, Tinkelman DG, van As A, Liddle RF.
    Chest; 1994 Apr 22; 105(4):1032-7. PubMed ID: 7909285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.